Global Colloids Blood Plasma Market Size Likely to Grow at a CAGR of 5.3% By 2035

The global colloids blood plasma market size is expected to be 3.5 billion USD in 2025. It is also expected to grow to 3.68 billion USD in 2026 and to about 5.91 billion USD in 2035, with an annual CAGR of 5.3% between 2026 and 2035.

Colloids Blood Plasma Market Revenue and Trends  

Colloids Blood Plasma Market represents a crucial segment in the health care and critical care industry; these blood plasma markets are very essential in managing and maintaining volume in the blood and facilitating fluid resuscitation in trauma surgery, shock, Burns and other emergency medical conditions. Hypovolemia, shock, burns, severe dehydration and tissue perfusion and circulation require these products, owing to increased number of surgical procedures, increasing number of trauma cases, and need for effective plasma volume expanders in critical care and surgical procedures, The demand for blood plasma markets are gaining growth in a constant manner with rise in elderly population, prevalence of chronic diseases and use of effective colloid solutions.

Growing awareness and use of efficient formulations, increased safety profile of colloids are helping the Colloids Blood Plasma Markets to expand their global reach, rising investment in health care sectors, expanding healthcare infrastructure and favorable government support in various countries such as Europe, North America and Asia Pacific regions are further aiding the Colloids Blood Plasma Market to grow consistently with ongoing research to expand the efficiency, accessibility and effectiveness of colloid solutions.

What are the Factors of the Colloids Blood Plasma Market with an Effect of a Major Influence in its Development?  

The growing demand in emergency and critical care environments, where precise volume management and swift replacement of fluid volumes are essential, is the main driving factor of the Colloids Blood Plasma Market development. This growth in the market is also fueled by the increasing rates of trauma and surgical cases, as well as Burns, Hypovolemia, shock, and related conditions leading to an urgent demand for plasma volume expanders, to help stabilize hemodynamics and improve the patient outcomes. A rise in the chronic diseases incidence as well as an increasing rate in the aging population susceptible to surgeries and critical illnesses have added significantly to the demand of colloids to various hospitals, and urgent cares.

 The expansion of the market is driven by the technological progress of the formulation of colloids, and the requirement for better, safer solutions. Advancements in colloids such as improved compatibility, minimal side effects, better effectiveness in the market, which directly reflects in a better clinical performance, are helping to increase its usage. Moreover, advancement of the health industry through rise in healthcare expenses and improvement in the health infrastructure- especially in the developing regions, are assisting in the increase of this market's worth. The growing understanding regarding critical care management with colloids; supported by favorable government policies, as well as increasing research, will help in improving the product quality, access to care, thus contributing to sustain the market's growth over the world.

Segment Insight

By Product Type

Albumin-Based Colloids dominate the Colloids Blood Plasma Market because of its high efficacy, biocompatibility and its extensive use in the critical care patients for maintaining volume expansion as well as oncotic pressure. As these colloids are widely used in cases of trauma, burns, as well as in patients with liver disorders, the hospitals find these colloid solutions as the most preferred choice. Hydroxyethyl Starch (HES)-Based Colloids also find a good place among the hospital staff for plasma volume expansion during surgeries and emergencies, however these are used by following certain government regulations and concerns of safety. Gelatin-Based Colloids find applications due to its cost effectiveness and shorter half-life thus suitable for short term volume replacement. Dextran-Based Colloids while effective are at moderate growth rate due to side effects, but find uses in improving the microcirculation. Other colloid solutions are also being formulated in new ways to develop novel products with superior benefits.

By Application

Surgery accounts for the largest share in the market due to the high demand for fluid management and blood volume maintenance during the operative procedures. Trauma and Injury is another largest segment because of increasing number of accidents and cases of emergency where immediate resuscitation is essential. Shock management as in the cases of septic shock and hypovolemic shock largely contributes to market demand because of need to immediately stabilize the condition of patients. Burns are a major application of the colloid solution in restoring fluid balance and avoiding further complications. Other applications such as Critical care and Intensive care unit treatments are also contributing to market growth.

By End-User

Hospitals dominate the Colloids Blood Plasma Market due to the availability of extensive health infrastructure facilities, high patient load as well as specialized critical care units. The Ambulatory Surgical Centers segment is gaining a steady momentum owing to their cost-effective treatment and fast surgery which helps in increasing the demand for plasma expanders. The Specialty Clinics segment is another important contributor because these specialized clinics provide a targeted approach in dealing with the certain diseases where fluid management is an important aspect. Other end-users include emergency care unit, home healthcare and other facilities.

By Region:   

North America is the leading market in the Colloids Blood Plasma Market due to its well-developed healthcare sector, high per capita health care spending and advanced technology in use. Europe is the second largest region due to its well-developed health infrastructure facilities and growing concern for improving critical care. Asia Pacific is the fastest growing market due to increasing health awareness among the general public, well-developing health infrastructure facilities and rise in trauma and surgical cases especially in the Chinese and Indian market. Latin America and Middle East & Africa are also registering a moderate growth rate due to improving health care facilities and increase in investments in medical field.

Report Scope

Recent Developments

• March 2024 LFB Group revealed innovations in plasma derived therapies and albumin based colloid solutions with emphasis on increasing effectiveness of critical care and emergency treatments. It is increasing its manufacturing capacities and research and development into cutting-edge plasma fractionation techniques as a response to the global demand of safe and efficacious blood plasma products for use during surgery, trauma and critical care therapies.

List of the prominent players in the Colloids Blood Plasma Market:

• CSL Behring

• Grifols S.A.

• Octapharma AG

• Kedrion Biopharma

• Shire (now part of Takeda Pharmaceutical Company Limited)

• Bio Products Laboratory Ltd.

• Sanquin Blood Supply Foundation

• China Biologic Products Holdings Inc.

• LFB Group

• Biotest AG

• Green Cross Corporation

• Baxter International Inc.

• Hualan Biological Engineering Inc.

• Shanghai RAAS Blood Products Co. Ltd.

• Emergent BioSolutions Inc.

• Kamada Ltd.

• ADMA Biologics Inc.

• Intas Pharmaceuticals Ltd.

• BPL Plasma

• PlasmaGen BioSciences Pvt. Ltd.

• Others

The Colloids Blood Plasma Market is segmented as follows:

By Product Type

• Gelatin-Based Colloids

• Dextran-Based Colloids

• Hydroxyethyl Starch-Based Colloids

• Albumin-Based Colloids

• Others

By Application

• Trauma and Injury

• Surgery

• Burns

• Shock

• Others

By End Use

• Hospitals

• Ambulatory Surgical Centers

• Specialty Clinics

• Others

Regional Coverage:

North America

• U.S.

• Canada

• Mexico

• Rest of North America 

Europe

• Germany

• France

• U.K.

• Russia

• Italy

• Spain

• Netherlands

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• New Zealand

• Australia

• South Korea

• Taiwan

• Rest of Asia Pacific 

The Middle East & Africa

• Saudi Arabia

• UAE

• Egypt

• Kuwait

• South Africa

• Rest of the Middle East & Africa

Latin America

• Brazil

• Argentina

• Rest of Latin America